4.5 Letter

CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome

Journal

CLINICAL AND EXPERIMENTAL DERMATOLOGY
Volume 47, Issue 12, Pages 2284-2285

Publisher

WILEY
DOI: 10.1111/ced.15354

Keywords

-

Categories

Funding

  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23AR074530]

Ask authors/readers for more resources

This article describes a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumors, and various malignancies.
CDKN2A at chromosome positon 9p21 is a tumour suppressor gene encoding the cell cycle regulators p16 and p14ARF. While melanoma is associated with variants affecting both transcripts, families with mutations involving the p14ARF-specific exon 1B may be predisposed to central nervous system tumours. We describe a family with a deletion of exon 1B in CDKN2A, who had multiple cutaneous melanomas, neural tumours and various malignancies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available